Tapewire

Nasdaq · USD

IRTC

iRhythm Holdings, Inc.

Export transactions ↓
Tapewire entity
1499
SEC CIK
0001388658
Parsed reports
491

Last 12 months

Inside the activity.

1 purchase rows · 65 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202507
Dec 202502
Jan 202600
Feb 2026014
Mar 2026023
Apr 202600
May 202616
Jun 202602
Jul 202602
Aug 202608
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 02, 2026 Filed Sep 3, 2026 20:01 UTC
Wilson Daniel G.Chief Financial Officer
SaleCommon Stock 773 $121.83 $94,174.59
Disclosure

SEC source: 0001860745-26-000008 · wk-form4_1788465675.xml · nonDerivative · entry 1

Wilson Daniel G. · CIK 0001860745 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,887

F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs).

Read SEC document
August 10, 2026 Filed Aug 11, 2026 20:01 UTC
Shrishrimal SumiEVP, Chief Risk Officer
SaleCommon Stock 5,372 $124.65 $669,640.75
Disclosure

SEC source: 0001850687-26-000010 · wk-form4_1786478483.xml · nonDerivative · entry 2

Shrishrimal Sumi · CIK 0001850687 · EVP, Chief Risk Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,621

F2 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of performance RSUs.

Read SEC document
August 10, 2026 Filed Aug 11, 2026 20:01 UTC
Patterson ChadCHIEF COMM & PRODUCT OFFICER
SaleCommon Stock 7,093 $124.65 $884,170.11
Disclosure

SEC source: 0001850152-26-000012 · wk-form4_1786478507.xml · nonDerivative · entry 2

Patterson Chad · CIK 0001850152 · CHIEF COMM & PRODUCT OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,125

F2 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of performance RSUs.

Read SEC document
August 10, 2026 Filed Aug 11, 2026 20:02 UTC SaleCommon Stock 7,093 $124.65 $884,155.93
Disclosure

SEC source: 0001692785-26-000009 · wk-form4_1786478535.xml · nonDerivative · entry 2

Murphy Patrick Michael · CIK 0001692785 · CBO and CLO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,699

F2 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of performance RSUs.

Read SEC document
August 10, 2026 Filed Aug 11, 2026 20:02 UTC
Blackford Quentin S.Director · President and CEO
SaleCommon Stock 26,859 $124.65 $3,348,011.95
Disclosure

SEC source: 0001612451-26-000012 · wk-form4_1786478560.xml · nonDerivative · entry 2

Blackford Quentin S. · CIK 0001612451 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 226,008

F2 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of performance RSUs.

Read SEC document
August 10, 2026 Filed Aug 11, 2026 20:00 UTC
Turakhia MinangCHIEF MED/SCI OFCR EVP ADVTECH
SaleCommon Stock 7,093 $124.65 $884,150.96
Disclosure

SEC source: 0001932682-26-000012 · wk-form4_1786478447.xml · nonDerivative · entry 2

Turakhia Minang · CIK 0001932682 · CHIEF MED/SCI OFCR EVP ADVTECH

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,116

F2 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of performance RSUs.

Read SEC document
August 07, 2026 Filed Aug 11, 2026 20:01 UTC
Shrishrimal SumiEVP, Chief Risk Officer
GrantCommon Stock 9,706 $0.00 $0.00
Disclosure

SEC source: 0001850687-26-000010 · wk-form4_1786478483.xml · nonDerivative · entry 1

Shrishrimal Sumi · CIK 0001850687 · EVP, Chief Risk Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,993

F1 · shares: Represents the acquisition of shares upon the determination of the Compensation & Human Capital Management Committee of the Board of Directors of the Issuer that the performance conditions were met with respect to performance Restricted Stock Units ("RSUs") granted to the Reporting Person on August 7, 2023.

Read SEC document
August 07, 2026 Filed Aug 11, 2026 20:01 UTC
Patterson ChadCHIEF COMM & PRODUCT OFFICER
GrantCommon Stock 13,589 $0.00 $0.00
Disclosure

SEC source: 0001850152-26-000012 · wk-form4_1786478507.xml · nonDerivative · entry 1

Patterson Chad · CIK 0001850152 · CHIEF COMM & PRODUCT OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,218

F1 · shares: Represents the acquisition of shares upon the determination of the Compensation & Human Capital Management Committee of the Board of Directors of the Issuer that the performance conditions were met with respect to performance Restricted Stock Units ("RSUs") granted to the Reporting Person on August 7, 2023.

Read SEC document
August 07, 2026 Filed Aug 11, 2026 20:02 UTC GrantCommon Stock 13,589 $0.00 $0.00
Disclosure

SEC source: 0001692785-26-000009 · wk-form4_1786478535.xml · nonDerivative · entry 1

Murphy Patrick Michael · CIK 0001692785 · CBO and CLO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,792

F1 · shares: Represents the acquisition of shares upon the determination of the Compensation & Human Capital Management Committee of the Board of Directors of the Issuer that the performance conditions were met with respect to performance Restricted Stock Units ("RSUs") granted to the Reporting Person on August 7, 2023.

Read SEC document
August 07, 2026 Filed Aug 11, 2026 20:02 UTC
Blackford Quentin S.Director · President and CEO
GrantCommon Stock 48,534 $0.00 $0.00
Disclosure

SEC source: 0001612451-26-000012 · wk-form4_1786478560.xml · nonDerivative · entry 1

Blackford Quentin S. · CIK 0001612451 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 252,867

F1 · shares: Represents the acquisition of shares upon the determination of the Compensation & Human Capital Management Committee of the Board of Directors of the Issuer that the performance conditions were met with respect to performance Restricted Stock Units ("RSUs") granted to the Reporting Person on August 7, 2023.

Read SEC document
August 07, 2026 Filed Aug 11, 2026 20:00 UTC
Turakhia MinangCHIEF MED/SCI OFCR EVP ADVTECH
GrantCommon Stock 13,589 $0.00 $0.00
Disclosure

SEC source: 0001932682-26-000012 · wk-form4_1786478447.xml · nonDerivative · entry 1

Turakhia Minang · CIK 0001932682 · CHIEF MED/SCI OFCR EVP ADVTECH

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,209

F1 · shares: Represents the acquisition of shares upon the determination of the Compensation & Human Capital Management Committee of the Board of Directors of the Issuer that the performance conditions were met with respect to performance Restricted Stock Units ("RSUs") granted to the Reporting Person on August 7, 2023.

Read SEC document
August 03, 2026 Filed Aug 4, 2026 20:01 UTC
Patterson ChadCHIEF COMM & PRODUCT OFFICER
SaleCommon Stock 2,712 $122.12 $331,191.88
Disclosure

SEC source: 0001850152-26-000010 · wk-form4_1785873670.xml · nonDerivative · entry 1

Patterson Chad · CIK 0001850152 · CHIEF COMM & PRODUCT OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,629

F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs).

Read SEC document
August 03, 2026 Filed Aug 4, 2026 20:02 UTC
Smith MervinEVP Strategic Business Ops
SaleCommon Stock 617 $122.12 $75,348.60
Disclosure

SEC source: 0001985217-26-000012 · wk-form4_1785873735.xml · nonDerivative · entry 1

Smith Mervin · CIK 0001985217 · EVP Strategic Business Ops

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,410

F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs).

Read SEC document
August 03, 2026 Filed Aug 4, 2026 20:01 UTC
Rodda JulianneEVP, CHIEF PEOPLE OFFICER
SaleCommon Stock 2,112 $122.12 $257,919.34
Disclosure

SEC source: 0002125725-26-000004 · wk-form4_1785873709.xml · nonDerivative · entry 1

Rodda Julianne · CIK 0002125725 · EVP, CHIEF PEOPLE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,201

F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs).

Read SEC document
July 02, 2026 Filed Jul 6, 2026 20:03 UTC
Freeman Sean ClintonEVP, Strategy & Corp Devt
SaleCommon Stock 918 $124.71 $114,483.78
Disclosure

SEC source: 0002074661-26-000006 · wk-form4_1783368198.xml · nonDerivative · entry 1

Freeman Sean Clinton · CIK 0002074661 · EVP, Strategy & Corp Devt

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,641

F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs).

Read SEC document
July 02, 2026 Filed Jul 6, 2026 20:03 UTC
Turakhia MinangCHIEF MED/SCI OFCR EVP ADVTECH
SaleCommon Stock 1,423 $124.71 $177,462.33
Disclosure

SEC source: 0001932682-26-000010 · wk-form4_1783368216.xml · nonDerivative · entry 1

Turakhia Minang · CIK 0001932682 · CHIEF MED/SCI OFCR EVP ADVTECH

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,620

F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs).

Read SEC document
June 02, 2026 Filed Jun 3, 2026 20:16 UTC
Shrishrimal SumiEVP, Chief Risk Officer
SaleCommon Stock 1,716 $108.19 $185,652.50
Disclosure

SEC source: 0001850687-26-000008 · wk-form4_1780517759.xml · nonDerivative · entry 2

Shrishrimal Sumi · CIK 0001850687 · EVP, Chief Risk Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,287

F2 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs).

Read SEC document
June 02, 2026 Filed Jun 3, 2026 20:15 UTC
Rosenbaum Marc WadeChief Accounting Officer
SaleCommon Stock 729 $108.19 $78,870.00
Disclosure

SEC source: 0001929535-26-000011 · wk-form4_1780517714.xml · nonDerivative · entry 2

Rosenbaum Marc Wade · CIK 0001929535 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,155

F2 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs).

Read SEC document
May 29, 2026 Filed Jun 1, 2026 20:31 UTC
Freeman Sean ClintonEVP, Strategy & Corp Devt
GrantCommon Stock 273 $96.82 $26,430.50
Disclosure

SEC source: 0002074661-26-000004 · wk-form4_1780345898.xml · nonDerivative · entry 1

Freeman Sean Clinton · CIK 0002074661 · EVP, Strategy & Corp Devt

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,559

F1 · shares: Mr. Freeman is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2016 Employee Stock Purchase Plan for the purchase period December 1, 2025 through May 31, 2026. This transaction is exempt from Section 16(b) under Rule 16b-3.

Read SEC document
May 29, 2026 Filed Jun 1, 2026 20:34 UTC
Patterson ChadCHIEF COMM & PRODUCT OFFICER
GrantCommon Stock 177 $96.82 $17,136.26
Disclosure

SEC source: 0001850152-26-000008 · wk-form4_1780346050.xml · nonDerivative · entry 1

Patterson Chad · CIK 0001850152 · CHIEF COMM & PRODUCT OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,341

F1 · shares: Mr. Patterson is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2016 Employee Stock Purchase Plan for the purchase period December 1, 2025 through May 31, 2026. This transaction is exempt from Section 16(b) under Rule 16b-3.

Read SEC document
May 29, 2026 Filed Jun 1, 2026 20:26 UTC
Blackford Quentin S.Director · President and CEO
GrantCommon Stock 178 $96.82 $17,233.07
Disclosure

SEC source: 0001612451-26-000008 · wk-form4_1780345611.xml · nonDerivative · entry 1

Blackford Quentin S. · CIK 0001612451 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 204,333

F1 · shares: Mr. Blackford is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2016 Employee Stock Purchase Plan for the purchase period December 1, 2025 through May 31, 2026. This transaction is exempt from Section 16(b) under Rule 16b-3.

Read SEC document
May 29, 2026 Filed Jun 1, 2026 20:36 UTC
Turakhia MinangCHIEF MED/SCI OFCR EVP ADVTECH
GrantCommon Stock 137 $96.82 $13,263.66
Disclosure

SEC source: 0001932682-26-000008 · wk-form4_1780346187.xml · nonDerivative · entry 1

Turakhia Minang · CIK 0001932682 · CHIEF MED/SCI OFCR EVP ADVTECH

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,043

F1 · shares: Mr. Turakhia is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2016 Employee Stock Purchase Plan for the purchase period December 1, 2025 through May 31, 2026. This transaction is exempt from Section 16(b) under Rule 16b-3.

Read SEC document
May 29, 2026 Filed Jun 3, 2026 20:16 UTC
Shrishrimal SumiEVP, Chief Risk Officer
GrantCommon Stock 133 $96.82 $12,876.40
Disclosure

SEC source: 0001850687-26-000008 · wk-form4_1780517759.xml · nonDerivative · entry 1

Shrishrimal Sumi · CIK 0001850687 · EVP, Chief Risk Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,003

F1 · shares: Ms. Shrishrimal is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2016 Employee Stock Purchase Plan for the purchase period December 1, 2025 through May 31, 2026. This transaction is exempt from Section 16(b) under Rule 16b-3.

Read SEC document
May 29, 2026 Filed Jun 3, 2026 20:15 UTC
Rosenbaum Marc WadeChief Accounting Officer
GrantCommon Stock 178 $96.82 $17,233.07
Disclosure

SEC source: 0001929535-26-000011 · wk-form4_1780517714.xml · nonDerivative · entry 1

Rosenbaum Marc Wade · CIK 0001929535 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,884

F1 · shares: Mr. Rosenbaum is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2016 Employee Stock Purchase Plan for the purchase period December 1, 2025 through May 31, 2026. This transaction is exempt from Section 16(b) under Rule 16b-3.

Read SEC document
May 27, 2026 Filed May 29, 2026 20:02 UTC GrantCommon Stock 1,573 $0.00 $0.00
Disclosure

SEC source: 0001203567-26-000003 · wk-form4_1780084972.xml · nonDerivative · entry 1

OBOYLE KEVIN C · CIK 0001203567 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,608

F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting.

Read SEC document
May 27, 2026 Filed May 29, 2026 16:03 UTC GrantCommon Stock 1,573 $0.00 $0.00
Disclosure

SEC source: 0001188264-26-000003 · wk-form4_1780085008.xml · nonDerivative · entry 1

MCGINNIS KAREN K · CIK 0001188264 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,608

F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting.

Read SEC document
May 27, 2026 Filed May 29, 2026 20:02 UTC GrantCommon Stock 1,573 $0.00 $0.00
Disclosure

SEC source: 0001316065-26-000010 · wk-form4_1780084916.xml · nonDerivative · entry 1

TALWALKAR ABHIJIT Y · CIK 0001316065 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,872

F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting.

Read SEC document
May 27, 2026 Filed May 29, 2026 20:05 UTC GrantCommon Stock 1,573 $0.00 $0.00
Disclosure

SEC source: 0001738783-26-000003 · wk-form4_1780085118.xml · nonDerivative · entry 1

Bairey Merz Cathleen Noel · CIK 0001738783 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,546

F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting.

Read SEC document
May 27, 2026 Filed May 29, 2026 20:04 UTC GrantCommon Stock 1,573 $0.00 $0.00
Disclosure

SEC source: 0001527009-26-000003 · wk-form4_1780085085.xml · nonDerivative · entry 1

Bodaken Bruce G. · CIK 0001527009 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,211

F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting.

Read SEC document
May 27, 2026 Filed May 29, 2026 20:04 UTC
Ling KarenDirector
GrantCommon Stock 1,573 $0.00 $0.00
Disclosure

SEC source: 0001597450-26-000003 · wk-form4_1780085051.xml · nonDerivative · entry 1

Ling Karen · CIK 0001597450 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,141

F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting.

Read SEC document
May 27, 2026 Filed May 29, 2026 20:01 UTC
YOOR BRIAN BDirector
GrantCommon Stock 1,573 $0.00 $0.00
Disclosure

SEC source: 0001643528-26-000003 · wk-form4_1780084869.xml · nonDerivative · entry 1

YOOR BRIAN B · CIK 0001643528 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,171

F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of IRTC Common Stock. The vesting occurs on the earlier of (i) one year after grant or the (ii) the date of the company's next annual meeting.

Read SEC document
May 11, 2026 Filed May 12, 2026 21:12 UTC Exercise / conversionEmployee Stock Option (right to buy) · Derivative 5,312 $10.71 Strike: $10.71 $56,891.52
Disclosure

SEC source: 0001316065-26-000007 · wk-form4_1778620325.xml · derivative · entry 7

TALWALKAR ABHIJIT Y · CIK 0001316065 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,312 shares

Expires 2026-05-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.expiration_date: The option, originally granted on May 23, 2016 for 21,248 shares, vested in thirty-six equal monthly installments. This option has an expiration date of May 23, 2026. The Rule 10b5-1 trading plan of Mr. Talwalkar solely covers shares subject to options expiring in 2026 and 2027.

Read SEC document
May 11, 2026 Filed May 12, 2026 21:12 UTC SaleCommon Stock 290 $120.53 $34,953.70
Disclosure

SEC source: 0001316065-26-000007 · wk-form4_1778620325.xml · nonDerivative · entry 6

TALWALKAR ABHIJIT Y · CIK 0001316065 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,299

F1 · shares: All transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by Mr. Talwalkar on May 12, 2025.

Read SEC document
May 11, 2026 Filed May 12, 2026 21:12 UTC SaleCommon Stock 1,147 $119.16 $136,671.59
Disclosure

SEC source: 0001316065-26-000007 · wk-form4_1778620325.xml · nonDerivative · entry 5

TALWALKAR ABHIJIT Y · CIK 0001316065 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,589

F1 · shares: All transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by Mr. Talwalkar on May 12, 2025.

F5 · price: Represents the weighted-average sale price per share of a series of transactions, all of which were executed on May 11, 2026. The actual sale prices ranged from a low of $118.70 to a high of $119.63, inclusive. Mr. Talwalkar undertakes to provide upon request of the SEC staff, iRhythm Holdings, Inc. or any security holder of iRhythm Holdings, Inc., full information regarding the numbers of shares sold at each price within the range. The weighted-average sale price reflected has been rounded to 4 decimal points.

Read SEC document
May 11, 2026 Filed May 12, 2026 21:12 UTC SaleCommon Stock 2,293 $118.02 $270,611.38
Disclosure

SEC source: 0001316065-26-000007 · wk-form4_1778620325.xml · nonDerivative · entry 4

TALWALKAR ABHIJIT Y · CIK 0001316065 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,736

F1 · shares: All transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by Mr. Talwalkar on May 12, 2025.

F4 · price: Represents the weighted-average sale price per share of a series of transactions, all of which were executed on May 11, 2026. The actual sale prices ranged from a low of $117.68 to a high of $118.45, inclusive. Mr. Talwalkar undertakes to provide upon request of the SEC staff, iRhythm Holdings, Inc. or any security holder of iRhythm Holdings, Inc., full information regarding the numbers of shares sold at each price within the range. The weighted-average sale price reflected has been rounded to 4 decimal points.

Read SEC document
May 11, 2026 Filed May 12, 2026 21:12 UTC SaleCommon Stock 642 $116.98 $75,101.93
Disclosure

SEC source: 0001316065-26-000007 · wk-form4_1778620325.xml · nonDerivative · entry 3

TALWALKAR ABHIJIT Y · CIK 0001316065 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 24,029

F1 · shares: All transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by Mr. Talwalkar on May 12, 2025.

F3 · price: Represents the weighted-average sale price per share of a series of transactions, all of which were executed on May 11, 2026. The actual sale prices ranged from a low of $116.62 to a high of $117.31, inclusive. Mr. Talwalkar undertakes to provide upon request of the SEC staff, iRhythm Holdings, Inc. or any security holder of iRhythm Holdings, Inc., full information regarding the numbers of shares sold at each price within the range. The weighted-average sale price reflected has been rounded to 4 decimal points.

Read SEC document
May 11, 2026 Filed May 12, 2026 21:12 UTC SaleCommon Stock 940 $116.05 $109,090.95
Disclosure

SEC source: 0001316065-26-000007 · wk-form4_1778620325.xml · nonDerivative · entry 2

TALWALKAR ABHIJIT Y · CIK 0001316065 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 24,671

F1 · shares: All transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by Mr. Talwalkar on May 12, 2025.

F2 · price: Represents the weighted-average sale price per share of a series of transactions, all of which were executed on May 11, 2026. The actual sale prices ranged from a low of $115.61 to a high of $116.61, inclusive. Mr. Talwalkar undertakes to provide upon request of the SEC staff, iRhythm Holdings, Inc. or any security holder of iRhythm Holdings, Inc., full information regarding the numbers of shares sold at each price within the range. The weighted-average sale price reflected has been rounded to 4 decimal points.

Read SEC document
May 11, 2026 Filed May 12, 2026 21:12 UTC PurchaseCommon Stock 5,312 $10.71 $56,891.52
Disclosure

SEC source: 0001316065-26-000007 · wk-form4_1778620325.xml · nonDerivative · entry 1

TALWALKAR ABHIJIT Y · CIK 0001316065 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,611

F1 · shares: All transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by Mr. Talwalkar on May 12, 2025.

Read SEC document
May 04, 2026 Filed May 5, 2026 20:36 UTC
Lawrence Brian LeeChief Technology Officer
SaleCommon Stock 1,014 $120.80 $122,491.20
Disclosure

SEC source: 0001506228-26-000004 · wk-form4_1778013380.xml · nonDerivative · entry 1

Lawrence Brian Lee · CIK 0001506228 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,154

F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs).

Read SEC document
March 16, 2026 Filed Mar 17, 2026 20:31 UTC
Smith MervinEVP Strategic Business Ops
SaleCommon Stock 2,585 $114.30 $295,465.50
Disclosure

SEC source: 0001985217-26-000010 · wk-form4_1773779492.xml · nonDerivative · entry 1

Smith Mervin · CIK 0001985217 · EVP Strategic Business Ops

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 23,027

F1 · shares: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on November 19, 2025.

Read SEC document
March 12, 2026 Filed Mar 19, 2026 21:39 UTC GrantCommon Stock 2,218 $0.00 $0.00
Disclosure

SEC source: 0002122682-26-000005 · wk-form4_1773956384.xml · nonDerivative · entry 1

Patten Jason H · CIK 0002122682 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,436

F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 33.33% of the RSUs vest on March 12, 2027 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.

Read SEC document
March 02, 2026 Filed Mar 3, 2026 18:21 UTC
Wilson Daniel G.Chief Financial Officer
SaleCommon Stock 1,261 $128.45 $161,978.60
Disclosure

SEC source: 0001860745-26-000006 · wk-form4_1772580108.xml · nonDerivative · entry 4

Wilson Daniel G. · CIK 0001860745 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,660

F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs).

Read SEC document
March 02, 2026 Filed Mar 3, 2026 18:21 UTC
Wilson Daniel G.Chief Financial Officer
SaleCommon Stock 564 $128.45 $72,447.10
Disclosure

SEC source: 0001860745-26-000006 · wk-form4_1772580108.xml · nonDerivative · entry 3

Wilson Daniel G. · CIK 0001860745 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,921

F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs).

Read SEC document
March 02, 2026 Filed Mar 3, 2026 18:21 UTC
Wilson Daniel G.Chief Financial Officer
SaleCommon Stock 815 $128.44 $104,679.50
Disclosure

SEC source: 0001860745-26-000006 · wk-form4_1772580108.xml · nonDerivative · entry 2

Wilson Daniel G. · CIK 0001860745 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,485

F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs).

Read SEC document
March 02, 2026 Filed Mar 3, 2026 18:21 UTC
Wilson Daniel G.Chief Financial Officer
SaleCommon Stock 755 $128.44 $96,971.22
Disclosure

SEC source: 0001860745-26-000006 · wk-form4_1772580108.xml · nonDerivative · entry 1

Wilson Daniel G. · CIK 0001860745 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,300

F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs).

Read SEC document
March 02, 2026 Filed Mar 3, 2026 23:39 UTC
Shrishrimal SumiEVP, Chief Risk Officer
SaleCommon Stock 978 $128.44 $125,615.88
Disclosure

SEC source: 0001850687-26-000006 · wk-form4_1772581162.xml · nonDerivative · entry 3

Shrishrimal Sumi · CIK 0001850687 · EVP, Chief Risk Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,870

F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs).

Read SEC document
March 02, 2026 Filed Mar 3, 2026 23:39 UTC
Shrishrimal SumiEVP, Chief Risk Officer
SaleCommon Stock 906 $128.44 $116,365.46
Disclosure

SEC source: 0001850687-26-000006 · wk-form4_1772581162.xml · nonDerivative · entry 2

Shrishrimal Sumi · CIK 0001850687 · EVP, Chief Risk Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,848

F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs).

Read SEC document
March 02, 2026 Filed Mar 3, 2026 23:39 UTC
Shrishrimal SumiEVP, Chief Risk Officer
SaleCommon Stock 946 $128.44 $121,502.54
Disclosure

SEC source: 0001850687-26-000006 · wk-form4_1772581162.xml · nonDerivative · entry 1

Shrishrimal Sumi · CIK 0001850687 · EVP, Chief Risk Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,754

F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs).

Read SEC document
March 02, 2026 Filed Mar 3, 2026 23:37 UTC
Patterson ChadCHIEF COMM & PRODUCT OFFICER
SaleCommon Stock 3,030 $128.44 $389,188.05
Disclosure

SEC source: 0001850152-26-000006 · wk-form4_1772581019.xml · nonDerivative · entry 2

Patterson Chad · CIK 0001850152 · CHIEF COMM & PRODUCT OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,164

F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs).

Read SEC document
March 02, 2026 Filed Mar 3, 2026 23:37 UTC
Patterson ChadCHIEF COMM & PRODUCT OFFICER
SaleCommon Stock 1,414 $128.44 $181,616.14
Disclosure

SEC source: 0001850152-26-000006 · wk-form4_1772581019.xml · nonDerivative · entry 1

Patterson Chad · CIK 0001850152 · CHIEF COMM & PRODUCT OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,194

F1 · shares: These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs).

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.